MyFinsight
Home
About
Contact
auph: the income statement
Download
Download image
License Collaboration
And Royalty Revenue
$2,841K
Product
$70,627K
Total revenue
$73,468K
(8.41%↑ Y/Y)
Interest income
$3,316K
(-22.29%↓ Y/Y)
Income (loss) from
operations
$29,745K
(153.19%↑ Y/Y)
Total operating
expenses
$43,723K
(-21.96%↓ Y/Y)
Net income before
income taxes
$31,962K
(115.86%↑ Y/Y)
Interest expense
$1,099K
(-9.02%↓ Y/Y)
Other expense, net
-$929K
(79.69%↑ Y/Y)
Research and development
$8,435K
(176.83%↑ Y/Y)
Selling, general and
administrative
$26,182K
(-38.20%↓ Y/Y)
Cost of revenue
$8,177K
(35.49%↑ Y/Y)
Unrealized gain (loss) on
available-for-sale securities
$156K
(-67.09%↓ Y/Y)
Net income
$31,551K
(119.87%↑ Y/Y)
Income tax expense
$411K
(-10.07%↓ Y/Y)
Comprehensive income
$31,707K
(113.89%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)